Abstract
Background: The role of Zn(II) in storage, insulin secretion and function has been documented, while plant phenolics have antioxidant and other pharmacological credence.
Objective: The study aimed at synthesizing a novel medicinal Zn(II) complex. The medicinal properties of zinc(II) and caffeic acid were considered in synthesizing a novel complex with promising and improved antioxidant and anti-hyperglycaemic attributes.
Methods: Complex synthesis was done using a 1:2 molar ratio of zinc acetate and caffeic acid and structurally characterized using NMR, FT-IR, high resolution-mass spectroscopy and HPLC. Its cellular toxicity was assessed in Chang liver cells and L-myotubes. In vitro, cellular, and isolated tissue models were used to evaluate the antioxidant and anti-hyperglycaemic properties of the complex relative to its precursors. Molecular docking was used to investigate the interaction with insulin signalling target proteins: GLUT-4 and protein kinase B (Akt/PKB).
Results: Zinc(II) and caffeic acid interacted via Zn:O4 coordination, with the complex having one moiety of Zn(II) and 2 moieties of caffeic acid. The complex showed in vitro radical scavenging, α- glucosidase and α-amylase inhibitory activity up to 2.6 folds stronger than caffeic acid. The ability to inhibit lipid peroxidation (IC50 = 26.4 μM) and GSH depletion (IC50 = 16.8 μM) in hepatocytes was comparable to that of ascorbic acid (IC50 = 24.5 and 29.2 μM) and about 2 folds stronger than caffeic acid. Complexation improved glucose uptake activity of caffeic acid in L-6 myotubes (EC50 = 23.4 versus 169 μM) and isolated rat muscle tissues (EC50 = 339 versus 603 μM). Molecular docking showed better interaction with insulin signalling target proteins (GLUT-4 and Akt/PKB) than caffeic acid. The complex was not hepatotoxic or myotoxic.
Conclusion: Data suggest a synergistic antioxidant and anti-hyperglycaemic potential between zinc and caffeic acid, which could be attributed to the Zn:O4 coordination. Thus, it may be of medicinal relevance.
Keywords: Zinc(II), caffeic acid, complexation, structure-function relationship, diabetes, oxidative stress.
Graphical Abstract
[http://dx.doi.org/10.2147/DMSO.S67400] [PMID: 25506234]
[PMID: 28539866]
[http://dx.doi.org/10.3390/ijms21176275] [PMID: 32872570]
[http://dx.doi.org/10.1161/CIRCRESAHA.110.223545] [PMID: 21030723]
[http://dx.doi.org/10.1111/j.1753-4887.2010.00296.x] [PMID: 20536779]
[http://dx.doi.org/10.1016/j.abb.2016.05.022] [PMID: 27262257]
[http://dx.doi.org/10.1016/j.phrs.2020.104744] [PMID: 32156651]
[http://dx.doi.org/10.1248/cpb.49.652] [PMID: 11383627]
[http://dx.doi.org/10.1016/j.lfs.2004.02.006] [PMID: 15172182]
[http://dx.doi.org/10.1007/s00775-004-0590-8] [PMID: 15378407]
[http://dx.doi.org/10.1248/bpb.b16-00797] [PMID: 28250273]
[http://dx.doi.org/10.3389/fonc.2019.00541] [PMID: 31293975]
[http://dx.doi.org/10.1016/j.tox.2005.09.011] [PMID: 16243424]
[http://dx.doi.org/10.1124/jpet.106.105163] [PMID: 16644902]
[http://dx.doi.org/10.1111/jphp.13322] [PMID: 32639035]
[http://dx.doi.org/10.1111/jfbc.13913] [PMID: 34453451]
[http://dx.doi.org/10.2174/1573406416666200929143257] [PMID: 32990538]
[http://dx.doi.org/10.1016/S0168-9452(02)00332-1]
[http://dx.doi.org/10.4314/ajtcam.v8i2.63202] [PMID: 22238496]
[http://dx.doi.org/10.1007/s13410-013-0120-8]
[http://dx.doi.org/10.1016/j.jep.2020.112744] [PMID: 32165174]
[http://dx.doi.org/10.1093/jpp/rgab086] [PMID: 34109975]
[http://dx.doi.org/10.1038/s41598-020-63913-9] [PMID: 32322091]
[http://dx.doi.org/10.1371/journal.pone.0191727] [PMID: 29373583]
[http://dx.doi.org/10.1155/2017/8379327] [PMID: 28164134]
[http://dx.doi.org/10.1016/j.dsx.2016.01.028] [PMID: 26806326]
[http://dx.doi.org/10.1155/2020/9829176] [PMID: 32411336]
[http://dx.doi.org/10.1111/jfbc.12601]
[http://dx.doi.org/10.1038/s41598-020-59451-z] [PMID: 32054964]
[http://dx.doi.org/10.3390/antiox6020024] [PMID: 28353636]
[http://dx.doi.org/10.1515/jbcpp-2013-0141] [PMID: 24825096]
[http://dx.doi.org/10.1002/14651858.CD005061.pub3] [PMID: 30592787]
[http://dx.doi.org/10.2337/diaspect.17.3.183]
[http://dx.doi.org/10.3389/fendo.2017.00006] [PMID: 28167928]
[http://dx.doi.org/10.2337/diab.41.8.982] [PMID: 1628774]
[http://dx.doi.org/10.1186/1758-5996-4-13] [PMID: 22515411]
[http://dx.doi.org/10.1016/j.jnutbio.2011.09.001] [PMID: 22227267]
[http://dx.doi.org/10.2119/2005-00029.Saltiel] [PMID: 16307172]